Trials / Recruiting
RecruitingNCT05389774
DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution
DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction (LCP) Artificial Intelligence Solution on Service Utilisation, Health Economics and Patient Outcomes
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Nottingham University Hospitals NHS Trust · Academic / Other
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multi-centre prospective observational cohort study recruiting patients with 5-30mm solid and part-solid pulmonary nodules that have been detected on CT chest scans performed as part of routine practice. The aim is to determine whether physician decision making with the AI-based LCP tool, generates clinical and health-economic benefits over the current standard of care of these patients.
Conditions
Timeline
- Start date
- 2023-03-23
- Primary completion
- 2025-08-01
- Completion
- 2025-08-01
- First posted
- 2022-05-25
- Last updated
- 2025-04-08
Locations
10 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05389774. Inclusion in this directory is not an endorsement.